---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-218503"
form_type: "8-K"
ticker: "PEPG"
cik: "0001835597"
company_name: "PepGen Inc."
filed_at: "2025-09-26T23:59:59+00:00"
generated_at: "2026-05-17T05:36:13.067665+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PepGen Inc. prices $100 million public offering of 31.25 million shares at $3.20 per share

## Summary
- PepGen entered into underwriting agreement with Leerink Partners and Stifel to sell 31,250,000 shares at $3.20 per share.
- Underwriters exercised in full their 30-day option to purchase an additional 4,687,500 shares.
- Net proceeds estimated at $107.6 million to fund FREEDOM-DM1 and FREEDOM2-DM1 clinical trials and for working capital.
- Offering expected to close on September 26, 2025, subject to customary conditions.
- Securities offered under an effective shelf registration statement filed with the SEC on June 28, 2024.

## SEC filing metadata
- accession: 0001193125-25-218503
- form_type: 8-K
- ticker: PEPG
- cik: 0001835597
- company_name: PepGen Inc.
- filed_at: 2025-09-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835597/000119312525218503/0001193125-25-218503-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835597/000119312525218503/d911432d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-218503
- JSON: https://secwatch.observer/filing/0001193125-25-218503.json
- Plain text: https://secwatch.observer/filing/0001193125-25-218503.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.